Yunnan Baiyao: Xiangsha Pingwei Granules have obtained the drug supplementary application approval
According to Yunnan Baiyao, the sugar-free research project for the Xiangsha Pingwei Granules, jointly undertaken by the Central Research Institute of Yunnan Baiyao Group and the Pharmaceutical Business Group, has received the supplementary application approval from the National Medical Products Administration
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments